España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Sinovac Biotech
SVA
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$5.85
NaN%
After Hours: Dec 24, 9:29 AM EDT
Get Report
Comment
Sinovac Biotech (SVA) Forecast
News
Earnings
Sinovac Biotech (SVA) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Sinovac Biotech (NASDAQ:SVA) Stock
Sinovac Biotech Stock (NASDAQ: SVA)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, August 16, 2024
SINOVAC H1 EPS $(0.11) Down From $(0.15) YoY;...
Benzinga Newsdesk
Monday, September 11, 2023
SINOVAC Updates on the Clinical Trial Progres...
Benzinga Newsdesk
Tuesday, September 05, 2023
Sinovac Biotech Board Unanimously Rejects an ...
Benzinga Newsdesk
Tuesday, August 29, 2023
Alternative Liquidity Index Offers To Acquire...
Benzinga Newsdesk
Wednesday, March 29, 2023
CSPC Pharma Wins China's mRNA Vaccine Race, But Just Not Fast Enough
The Bamboo Works
Wednesday, February 22, 2023
Sinovac Biotech Board Amends Shareholder Righ...
Benzinga Newsdesk
Thursday, January 05, 2023
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
Benzinga Insights
Tuesday, November 22, 2022
Jim Cramer Says China's Vaccines 'Don't Work' But Xi Won't Admit It
Adam Eckert
Friday, November 04, 2022
Reported Late Thursday, Sinovac Biotech's Var...
Benzinga Newsdesk
Tuesday, September 06, 2022
SINOVAC Approved to Initiate Clinical Trial for Its Omicron Containing COVID-19 Vaccine in Chile
Bill Haddad
Wednesday, August 03, 2022
Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial
Vandana Singh
SINOVAC COVID-19 Vaccine Approved For Use In ...
Benzinga Newsdesk
Friday, July 29, 2022
Shares of Chinese companies are trading lower...
Benzinga Newsdesk
Wednesday, July 13, 2022
Which COVID-19 Vaccine(s) Significantly Prevented Deaths - Read To Find Out
Vandana Singh
Tuesday, July 05, 2022
Benzinga's Top Ratings Upgrades, Downgrades For July 5, 2022
Benzinga Insights
Thursday, May 26, 2022
CanSino's Covid Vaccine Gets WHO Nod. But Is It Too Little, Too Late?
The Bamboo Works
Wednesday, January 26, 2022
New Energy Lands as Hottest Category Among Chinese Concept Stocks in 2021 – Bamboo Works Special Report
The Bamboo Works
Monday, January 24, 2022
Pfizer, AstraZeneca or J&J COVID-19 Shots Boost Sinovac Regime, Brazilian Study Shows
Vandana Singh
Monday, January 03, 2022
Sinovac's COVID-19 Vaccine With Pfizer Booster Less Effective Against Omicron: Reuters
Vandana Singh
Thursday, December 30, 2021
SINOVAC Reports Unaudited First Half 2021 Sal...
Benzinga Newsdesk
Thursday, December 23, 2021
Three Sinovac Doses Fail to Protect Against Omicron in Study
Charles Gross
Monday, December 13, 2021
Greatly Transformed Sinovac Set To Reawaken On Wall Street?
The Bamboo Works
Friday, December 03, 2021
Sinovac Says Beijing Settled Litigation Of It...
Benzinga Newsdesk
Tuesday, November 09, 2021
Preliminary Results Show SINOVAC's COVID-19 V...
Benzinga Newsdesk
Friday, September 24, 2021
Sinovac's COVID-19 Vaccine Shows Efficacy, But Lags Rivals In Malaysian Study: Reuters
Vandana Singh
Thursday, September 09, 2021
The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization
Shanthi Rexaline
New Research On SINOVAC's COVID-19 Vaccine Sh...
Benzinga Newsdesk
Wednesday, September 08, 2021
SINOVAC Announces COVID-19 Vaccine Approved F...
Benzinga Newsdesk
Thursday, August 26, 2021
Inovio To Start Global Late-Stage COVID-19 Vaccine Trial
Vandana Singh
Tuesday, August 10, 2021
SINOVAC Announces Positive Data on Booster Sh...
Benzinga Newsdesk
Tuesday, July 20, 2021
EMA Starts Rolling Review Of Glaxo - Sanofi COVID-19 Vaccine
Vandana Singh
Monday, July 19, 2021
SINOVAC Receives Approval on Sabin Strain Bas...
Benzinga Newsdesk
Friday, July 16, 2021
Lancet Study Shows BioNTech COVID-19 Vaccine Generates 10X Higher Antibody Levels Compared to Sinovac Shot
Vandana Singh
Wednesday, June 30, 2021
Sinovac Highlights Publication Of Phase I/II COVID-19 Study In The Lancet Infectious Diseases
Bill Haddad
Wednesday, June 02, 2021
SINOVAC Biotech Ltd Announces The World Healt...
Benzinga Newsdesk
Tuesday, June 01, 2021
WHO Approved Emergency Use Listing For COVID-...
Benzinga Newsdesk
Tuesday, May 25, 2021
Sanofi, Walvax COVID-19 Vaccine Phase 3 Trials to Commence in Mexico: Reuters
Vandana Singh
Monday, March 08, 2021
Sinovac COVID-19 Vaccine Prelim Data Shows Is...
Benzinga Newsdesk
Philippines, Moderna Reach 13M Vaccine Doses Supply Pact
Vandana Singh
Wednesday, February 17, 2021
Sinovac Vaccine Works On The UK And South Afr...
Benzinga Newsdesk
Tuesday, February 16, 2021
Hong Kong Advisory Panel Approves China's Sin...
Charles Gross
Monday, February 08, 2021
Sinovac Says Receives Conditional Marketing A...
Benzinga Newsdesk
Friday, February 05, 2021
Sinovac Announces The Results For Its Phase 3...
Benzinga Newsdesk
Wednesday, February 03, 2021
SinoVac Files For Conditional Market Authoriz...
Benzinga Newsdesk
Tuesday, February 02, 2021
UPDATE: Cassava Sciences Says Results Support...
Benzinga Newsdesk
Wednesday, January 20, 2021
WHO Doc Shows Expectation For Approval Of COV...
Benzinga Newsdesk
Tuesday, January 12, 2021
'Sinovac's #COVID19 #vaccine is 100% effectiv...
Benzinga Newsdesk
Monday, January 11, 2021
China's CoronaVac Vaccine Has A General Effic...
Benzinga Newsdesk
Thursday, January 07, 2021
Sauo Paulo's Butantan Institute Submitted Req...
Benzinga Newsdesk
Late Stage Trial Of Sinovac COVID-19 Vaccine ...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
